Preterm premature rupture of membranes: comparison between twin and singleton gestations

The Journal of Maternal-fetal Medicine
T D MylesA Bieniarz

Abstract

The purpose of this study was to evaluate the clinical characteristics and pregnancy outcomes of twin and singleton pregnancies complicated by preterm premature rupture of membranes (PROM) and to compare the groups to evaluate for differences in these areas. In this retrospective study, patients with a gestational age of < 36 weeks admitted between 1993 and 1996 with PROM were evaluated for their clinical characteristics and pregnancy outcomes. Twin and singleton pregnancies were compared and the results were evaluated for significant differences. Patients with lethal fetal anomalies, clinical chorioamnionitis at presentation, or fetal distress at presentation were excluded from analysis. Liberal use of tocolysis was provided to both groups of patients, as were serial doses of betamethasone and vitamin K. Twenty-eight sets of twins and 119 singleton pregnancies were included in the analysis. Differences were noted with respect to twin and singleton pregnancies for both latency period (4.26 days vs 8.6 days, P < 0.001) and birthweight (1,464 vs 1,698 g, P < 0.03). The birthweight for twins was an average of the pair. No differences were noted with respect to gestational age at time of rupture, maternal age, gravidity, parity, ra...Continue Reading

Citations

Oct 3, 2008·Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies·Katharina KleinElisabeth Krampl
Jul 9, 2011·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Robert M EhsanipoorJudith H Chung
Apr 2, 2008·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Jean-Charles PasquierGeorges Mellier
Sep 16, 2009·The Journal of Obstetrics and Gynaecology Research·Simin TaghaviMehrdad Sheikhvatan
Sep 15, 2014·American Journal of Obstetrics and Gynecology·Luchin F WongTracy A Manuck
Aug 16, 2014·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Aviad CohenEli Rimon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.